Authors
Ryan, SilkeArnaud, Claire
Fitzpatrick, Susan F
Gaucher, Jonathan
Tamisier, Renaud
Pépin, Jean-Louis
Issue Date
2019-06-26Keywords
SLEEP APNOEAOBESITY
Metadata
Show full item recordJournal
European respiratory review : an official journal of the European Respiratory SocietyDOI
10.1183/16000617.0006-2019PubMed ID
31243096Abstract
Obstructive sleep apnoea (OSA) is a major health concern worldwide and adversely affects multiple organs and systems. OSA is associated with obesity in >60% of cases and is independently linked with the development of numerous comorbidities including hypertension, arrhythmia, stroke, coronary heart disease and metabolic dysfunction. The complex interaction between these conditions has a significant impact on patient care and mortality. The pathophysiology of cardiometabolic complications in OSA is still incompletely understood; however, the particular form of intermittent hypoxia (IH) observed in OSA, with repetitive short cycles of desaturation and re-oxygenation, probably plays a pivotal role. There is fast growing evidence that IH mediates some of its detrimental effects through adipose tissue inflammation and dysfunction. This article aims to summarise the effects of IH on adipose tissue in experimental models in a comprehensive way. Data from well-designed controlled trials are also reported with the final goal of proposing new avenues for improving phenotyping and personalised care in OSA.Item Type
ArticleLanguage
enEISSN
1600-0617ae974a485f413a2113503eed53cd6c53
10.1183/16000617.0006-2019
Scopus Count
Collections
Related articles
- Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction.
- Authors: Ryan S
- Issue date: 2017 Apr 15
- Obstructive sleep apnoea and cardiovascular consequences: Pathophysiological mechanisms.
- Authors: Arnaud C, Bochaton T, Pépin JL, Belaidi E
- Issue date: 2020 May
- Impact of obstructive sleep apnoea and intermittent hypoxia on cardiovascular and cerebrovascular regulation.
- Authors: Beaudin AE, Waltz X, Hanly PJ, Poulin MJ
- Issue date: 2017 Jul 1
- Sleep apnoea and metabolic dysfunction.
- Authors: Bonsignore MR, Borel AL, Machan E, Grunstein R
- Issue date: 2013 Sep 1
- Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation.
- Authors: Murphy AM, Thomas A, Crinion SJ, Kent BD, Tambuwala MM, Fabre A, Pepin JL, Roche HM, Arnaud C, Ryan S
- Issue date: 2017 Apr